Clinical Trial Update: Donor-specific Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia (ALL) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating donor-specific allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Donor-specific allogeneic hematopoietic cell transplantation

Snippet

Sponsor: Asan Medical Center | Conditions: Acute Lymphoid Leukemia | Phase 2 | Status: TERMINATED